According to Matinas BioPharma's latest financial reports the company's current earnings (TTM) are -A$34.37 M. In 2023 the company made an earning of -A$34.42 M a decrease over its 2022 earnings that were of -A$31.5 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.